MYC and cancer: Our recent analysis of polarity-deficient human cancers revealed that the abundance of apoptotic cells at the tumor/stroma interface positively correlated with MYC protein levels in the nearby tumor parenchyma also at late stages (Di Giacomo et al., 2017b), suggesting MMCC may help shape cancer evolution during malignant progression.